Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: 2021-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-21-000386
Form type
SC 13G/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Mar 25, 2021
Reporting period
Mar 23, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub